Completed PHASE2 INTERVENTIONAL 2-arm NCT00676975

The Efficacy of Tradition Chinese Medicine in Patients With Irritable Bowel Syndrome (TCM-IBS)

Dose Escalation Trial of Traditional Chinese Medicine for Irritable Bowel Syndrome(TCM- IBS)

Sponsor: Chinese University of Hong Kong

Interventions Traditional Chinese Medicine Traditional Chinese Medicine Placebo

Updated 9 times since 2017 Last updated: Apr 24, 2017 Started: May 26, 2008 Primary completion: Dec 30, 2010 Completion: Aug 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Irritable Bowel Syndrome, this trial is completed. The trial is conducted by Chinese University of Hong Kong and has accumulated 9 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Mar 2022 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Mar 2022 [monthly]

Completed PHASE2

▶ Show 4 earlier versions

Sep 2019 — Jan 2021 [monthly]

Completed PHASE2
Jun 2018 — Sep 2019 [monthly]

Completed PHASE2
May 2017 — Jun 2018 [monthly]

Completed PHASE2

Status: Unknown Status → Completed
Jan 2017 — May 2017 [monthly]

Unknown Status PHASE2

First recorded

May 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chinese University of Hong Kong
National Center for Complementary and Integrative Health (NCCIH)
University of Maryland

Data source: Chinese University of Hong Kong

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hong Kong (sar), China